{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:35:29Z","timestamp":1790800529036,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bcp.2019.04.018","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T23:11:30Z","timestamp":1555542690000},"page":"252-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Telmisartan and\/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase\/sphingoine-1-phosphate pathway, and TLR4 receptors"],"prefix":"10.1016","volume":"164","author":[{"given":"Iman","family":"Alqarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yieldez A.","family":"Bassiouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3983-868X","authenticated-orcid":false,"given":"Amira M.","family":"Badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bcp.2019.04.018_b0005","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism-Clin. Exp."},{"issue":"8","key":"10.1016\/j.bcp.2019.04.018_b0010","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/ijms18081649","article-title":"Adipokines and non-alcoholic fatty liver disease: multiple interactions","volume":"18","author":"Adolph","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2019.04.018_b0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: what we need in the future","volume":"38","author":"Araujo","year":"2018","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.bcp.2019.04.018_b0020","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.3390\/ijms140611963","article-title":"In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)","volume":"14","author":"Kanuri","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2019.04.018_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/362847","article-title":"Role of toll-like receptors and their downstream molecules in the development of nonalcoholic fatty liver disease","volume":"2010","author":"Miura","year":"2010","journal-title":"Gastroenterol. Res. Practice"},{"issue":"12","key":"10.1016\/j.bcp.2019.04.018_b0030","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.bcp.2013.10.005","article-title":"Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1\/sphingosine 1-phosphate signaling pathway","volume":"86","author":"Wang","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2019.04.018_b0035","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/eji.200737898","article-title":"TLR4 and S1P receptors cooperate to enhance inflammatory cytokine production in human gingival epithelial cells","volume":"38","author":"Eskan","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"9\u201310","key":"10.1016\/j.bcp.2019.04.018_b0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00508-014-0661-y","article-title":"Nonalcoholic fatty liver disease and the renin-angiotensin system blockers in the patients with chronic kidney disease","volume":"127","author":"Orlic","year":"2015","journal-title":"Wien Klin Wochenschr"},{"issue":"6","key":"10.1016\/j.bcp.2019.04.018_b0045","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/me.2014-1388","article-title":"Inhibition of sphingosine Kinase 1 ameliorates angiotensin II-Induced hypertension and inhibits transmembrane calcium entry via store-operated calcium channel","volume":"29","author":"Wilson","year":"2015","journal-title":"Mol. Endocrinol."},{"issue":"8","key":"10.1016\/j.bcp.2019.04.018_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182329","article-title":"Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6","volume":"12","author":"Ohkura","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bcp.2019.04.018_b0055","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/jgh.12112","article-title":"Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis","volume":"28","author":"Shirai","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.bcp.2019.04.018_b0060","first-page":"521","article-title":"Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study","volume":"22","author":"Enjoji","year":"2008","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2019.04.018_b0065","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.toxlet.2014.02.016","article-title":"Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes","volume":"226","author":"Li","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2019.04.018_b0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2014.02.038","article-title":"Antihypertensive effect of caffeic acid and its analogs through dual renin-angiotensin-aldosterone system inhibition","volume":"730","author":"Bhullar","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.018_b0075","article-title":"Transcriptomic analysis of key genes involved in chlorogenic acid biosynthetic pathway and characterization of MaHCT from Morus alba L","author":"Zhao","year":"2018","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bcp.2019.04.018_b0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejphar.2013.12.024","article-title":"Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats","volume":"724","author":"Ibrahim","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.04.018_b0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pupt.2013.11.003","article-title":"Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K\/Akt\/eNOS pathway","volume":"28","author":"Li","year":"2014","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2019.04.018_b0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejphar.2009.04.042","article-title":"Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes","volume":"614","author":"Halici","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2019.04.018_b0095","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.jnutbio.2013.05.007","article-title":"Chlorogenic acid, a dietary polyphenol, protects acetaminophen-induced liver injury and its mechanism","volume":"24","author":"Ji","year":"2013","journal-title":"J. Nutr. Biochem."},{"issue":"7","key":"10.1016\/j.bcp.2019.04.018_b0100","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1631\/jzus.B1400346","article-title":"Chlorogenic acid prevents acetaminophen-induced liver injury: the involvement of CYP450 metabolic enzymes and some antioxidant signals","volume":"16","author":"Pang","year":"2015","journal-title":"J. Zhejiang Univ. Sci B"},{"key":"10.1016\/j.bcp.2019.04.018_b0105","series-title":"Carleton's Histological Technique","author":"Carleton","year":"1980"},{"issue":"5259","key":"10.1016\/j.bcp.2019.04.018_b0110","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.bcp.2019.04.018_b0115","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1111\/bph.12856","article-title":"Experimental design and analysis and their reporting: new guidance for publication in BJP","volume":"172","author":"Curtis","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.04.018_b0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","article-title":"Non-alcoholic fatty liver disease","volume":"15","author":"Neuschwander-Tetri","year":"2017","journal-title":"BMC Med."},{"issue":"10","key":"10.1016\/j.bcp.2019.04.018_b0125","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.3748\/wjg.v22.i10.2931","article-title":"Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression","volume":"22","author":"Abdel-Haleim","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bcp.2019.04.018_b0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrgastro.2010.191","article-title":"Animal models of nonalcoholic fatty liver disease","volume":"8","author":"Hebbard","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2019.04.018_b0135","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.biopha.2016.04.013","article-title":"The protective effect of juglanin on fructose-induced hepatitis by inhibiting inflammation and apoptosis through TLR4 and JAK2\/STAT3 signaling pathways in fructose-fed rats","volume":"81","author":"Zhou","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"s2","key":"10.1016\/j.bcp.2019.04.018_b0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2036.2005.02601.x","article-title":"role of oxidative stress in the progression of non-alcoholic steatosis","volume":"22","author":"Albano","year":"2005","journal-title":"Aliment Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2019.04.018_b0145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.tcb.2012.04.001","article-title":"Diverse ubiquitin signaling in NF-\u03baB activation","volume":"22","author":"Iwai","year":"2012","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.bcp.2019.04.018_b0150","first-page":"127","article-title":"The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease","volume":"13","author":"Polyzos","year":"2009","journal-title":"Hippokratia"},{"issue":"2","key":"10.1016\/j.bcp.2019.04.018_b0155","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/oby.21720","article-title":"Fatty liver promotes fibrosis in monkeys consuming high fructose","volume":"25","author":"Cydylo","year":"2017","journal-title":"Obesity"},{"issue":"11","key":"10.1016\/j.bcp.2019.04.018_b0160","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/ptr.5925","article-title":"Scopoletin supplementation ameliorates steatosis and inflammation in diabetic mice","volume":"31","author":"Choi","year":"2017","journal-title":"Phytother. Res."},{"issue":"10","key":"10.1016\/j.bcp.2019.04.018_b0165","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.bbalip.2015.07.002","article-title":"Novel role of TLR4 in NAFLD development: modulation of metabolic enzymes expression","volume":"1851","author":"Ferreira","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.bcp.2019.04.018_b0170","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nri1650","article-title":"Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network","volume":"5","author":"Rosen","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.04.018_b0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbior.2015.09.001","article-title":"Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation","volume":"60","author":"Pyne","year":"2016","journal-title":"Adv. Biol. Regul."},{"issue":"1","key":"10.1016\/j.bcp.2019.04.018_b0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tem.2008.09.004","article-title":"Sphingolipids: players in the pathology of metabolic disease","volume":"20","author":"Cowart","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bcp.2019.04.018_b0185","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1096\/fj.10-168351","article-title":"Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression","volume":"25","author":"Osawa","year":"2011","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.bcp.2019.04.018_b0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","article-title":"Role of ceramides in nonalcoholic fatty liver disease","volume":"23","author":"Pagadala","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bcp.2019.04.018_b0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/met.2013.0120","article-title":"TLR4 gene polymorphism in patients with nonalcoholic fatty liver disease in comparison to healthy controls","volume":"12","author":"Kiziltas","year":"2014","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"10","key":"10.1016\/j.bcp.2019.04.018_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109081","article-title":"Synergy between sphingosine 1-phosphate and lipopolysaccharide signaling promotes an inflammatory, angiogenic and osteogenic response in human aortic valve interstitial cells","volume":"9","author":"Fernandez-Pisonero","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2019.04.018_b0205","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3389\/fimmu.2017.01336","article-title":"TLR4 is essential for the expression of s1p-dependent asthma-like disease in mice","volume":"8","author":"Roviezzo","year":"2017","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2019.04.018_b0210","doi-asserted-by":"crossref","first-page":"e0163069","DOI":"10.1371\/journal.pone.0163069","article-title":"Renin-angiotensin system inhibitors, Type 2 diabetes and fibrosis progression: an observational study in patients with nonalcoholic fatty liver disease","volume":"11","author":"Pelusi","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bcp.2019.04.018_b0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/tox.22240","article-title":"Telmisartan ameliorates carbon tetrachloride-induced acute hepatotoxicity in rats","volume":"32","author":"Atawia","year":"2017","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2019.04.018_b0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1756-3305-6-199","article-title":"Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection","volume":"6","author":"Attia","year":"2013","journal-title":"Parasites Vectors"},{"issue":"8","key":"10.1016\/j.bcp.2019.04.018_b0225","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3748\/wjg.15.942","article-title":"Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis","volume":"15","author":"Georgescu","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.bcp.2019.04.018_b0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jphs.2015.10.005","article-title":"Chlorogenic acid protects against cholestatic liver injury in rats","volume":"129","author":"Wu","year":"2015","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2019.04.018_b0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jsps.2010.10.004","article-title":"Anti-inflammatory activity of telmisartan in rat models of experimentally-induced chronic inflammation: comparative study with dexamethasone","volume":"19","author":"Al-Hejjaj","year":"2011","journal-title":"Saudi Pharm. J."},{"issue":"1","key":"10.1016\/j.bcp.2019.04.018_b0240","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1742-2094-9-102","article-title":"Telmisartan directly ameliorates the neuronal inflammatory response to IL-1\u03b2 partly through the JNK\/c-Jun and NADPH oxidase pathways","volume":"9","author":"Pang","year":"2012","journal-title":"J. Neuroinflammation."},{"issue":"1","key":"10.1016\/j.bcp.2019.04.018_b0245","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijcard.2007.11.003","article-title":"Impact of telmisartan on coronary stenting in patients with acute myocardial infarction compared with enalapril","volume":"132","author":"Yokoyama","year":"2009","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.bcp.2019.04.018_b0250","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1007\/s11064-013-1058-4","article-title":"Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats","volume":"38","author":"Ola","year":"2013","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.bcp.2019.04.018_b0255","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbadis.2016.07.019","article-title":"The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance","volume":"1863","author":"Ramalingam","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"issue":"4\u20136","key":"10.1016\/j.bcp.2019.04.018_b0260","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000218173","article-title":"Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells","volume":"23","author":"Ji","year":"2009","journal-title":"Cell Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2019.04.018_b0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.etap.2007.12.008","article-title":"Neuroprotective effects of chlorogenic acid against apoptosis of PC12 cells induced by methylmercury","volume":"26","author":"Li","year":"2008","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.018_b0270","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cbi.2017.05.002","article-title":"Protective effect of chlorogenic acid against methotrexate induced oxidative stress, inflammation and apoptosis in rat liver: an experimental approach","volume":"272","author":"Ali","year":"2017","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.bcp.2019.04.018_b0275","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jnutbio.2011.06.018","article-title":"Protective effects of chlorogenic acid against ischemia\/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties","volume":"23","author":"Yun","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bcp.2019.04.018_b0280","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.biopha.2018.10.044","article-title":"Cardio-protective and antioxidant properties of caffeic acid and chlorogenic acid: mechanistic role of angiotensin converting enzyme, cholinesterase and arginase activities in cyclosporine induced hypertensive rats","volume":"109","author":"Agunloye","year":"2019","journal-title":"Biomed. Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.bcp.2019.04.018_b0285","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2867-6-7","article-title":"The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression","volume":"6","author":"Belkaid","year":"2006","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2019.04.018_b0290","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2014.01.015","article-title":"Chlorogenic acid attenuates lipopolysaccharide-induced mice mastitis by suppressing TLR4-mediated NF-\u03baB signaling pathway","volume":"729","author":"Ruifeng","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2019.04.018_b0295","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tox.2012.10.025","article-title":"Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway","volume":"303","author":"Shi","year":"2013","journal-title":"Toxicology"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219301534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219301534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:07:39Z","timestamp":1757768859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219301534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":59,"alternative-id":["S0006295219301534"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.04.018","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telmisartan and\/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase\/sphingoine-1-phosphate pathway, and TLR4 receptors","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}